NCT03868657View on ClinicalTrials.gov

The Physiological Effects of Human Ether-a-go-go-Related Gene (hERG)Blockade on Metabolism

NACompletedINTERVENTIONAL
Enrollment

44

Participants

Timeline

Start Date

January 28, 2019

Primary Completion Date

August 19, 2019

Study Completion Date

March 9, 2020

Conditions
Long QT SyndromeHypoglycemia
Interventions
DRUG

Moxifloxacin

Moxifloxacin is solely used to cause a known and for the drug well documented effect, namely blockade of the Kv11.1 channel.

DRUG

Placebo

Placebo

Trial Locations (1)

2200

University of Copenhagen, Department of Biomedical Sciences, Copenhagen

All Listed Sponsors
lead

Signe Torekov

OTHER

NCT03868657 - The Physiological Effects of Human Ether-a-go-go-Related Gene (hERG)Blockade on Metabolism | Biotech Hunter | Biotech Hunter